Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-020260

Chief Executive Officer gave up 5,526 shares (to pay taxes)

  • Chief Executive Officer acquired 11,833 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2021-03-10 Option exercise +11,833 194,024 D
Kulkarni Samarth Chief Executive Officer 2021-03-10 Shares withheld for taxes −5,526 $124.15 $686,053 188,498 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2021-03-11 Grant or award · Stock Option (Right to Buy) +100,000 100,000 D
Kulkarni Samarth Chief Executive Officer 2021-03-11 Grant or award · Restricted Stock Units +36,000 36,000 D
Loading xslF345X03/doc4.xml…